Get started
HISAMITSU PHARMA.HISAMITSU PHARMA.HISAMITSU PHARMA.

HISAMITSU PHARMA.

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

HPX chart


Full chart

HPX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.72 B‬ EUR
Dividend yield (indicated)
3.00%
Price to earnings Ratio (TTM)
13.6
Basic EPS (TTM)
1.8 EUR
Net income (FY)
‪139.23 M‬ EUR
Revenue (FY)
‪998.28 M‬ EUR
Shares float
‪33.44 M‬
Beta (1Y)
0.14

Employees


Employees (FY)
‪2.8 K‬
Change (1Y)
+40 +1.45%
Revenue / Employee (1Y)
‪356.66 K‬ EUR
Net income / Employee (1Y)
‪49.74 K‬ EUR

About HISAMITSU PHARMACEUTICAL CO INC


Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
hisamitsu.co.jp
Headquarters
Tosu
Founded
1847
ISIN
JP3784600003
FIGI
BBG000C5XMD5
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan.

Check out other big names from the same industry as HPX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

HPX news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of HPX is 23.4 EUR — it has decreased by −0.85% in the past 24 hours. Watch HISAMITSU PHARMA. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange HISAMITSU PHARMA. stocks are traded under the ticker HPX.
HPX stock has fallen by −0.85% compared to the previous week, the month change is a −5.65% fall, over the last year HISAMITSU PHARMA. has showed a 10.38% increase.
We've gathered analysts' opinions on HISAMITSU PHARMA. future price: according to them, HPX price has a max estimate of 28.61 EUR and a min estimate of 28.61 EUR. Watch HPX chart and read a more detailed HISAMITSU PHARMA. stock forecast: see what analysts think of HISAMITSU PHARMA. and suggest that you do with its stocks.
HPX reached its all-time high on Jun 20, 2018 with the price of 78.0 EUR, and its all-time low was 9.0 EUR and was reached on Aug 5, 2003. View more price dynamics on HPX chart.
See other stocks reaching their highest and lowest prices.
HPX stock is 0.85% volatile and has beta coefficient of 0.14. Track HISAMITSU PHARMA. stock price on the chart and check out the list of the most volatile stocks — is HISAMITSU PHARMA. there?
Today HISAMITSU PHARMA. has the market capitalization of ‪1.72 B‬, it has decreased by −3.74% over the last week.
Yes, you can track HISAMITSU PHARMA. financials in yearly and quarterly reports right on TradingView.
HISAMITSU PHARMA. is going to release the next earnings report on Jul 10, 2025. Keep track of upcoming events with our Earnings Calendar.
HPX net income for the last quarter is ‪51.82 M‬ EUR, while the quarter before that showed ‪28.80 M‬ EUR of net income which accounts for 79.96% change. Track more HISAMITSU PHARMA. financial stats to get the full picture.
HISAMITSU PHARMA. dividend yield was 2.13% in 2024, and payout ratio reached 30.45%. The year before the numbers were 2.19% and 46.80% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 4, 2025, the company has ‪2.8 K‬ employees. See our rating of the largest employees — is HISAMITSU PHARMA. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HISAMITSU PHARMA. EBITDA is ‪161.45 M‬ EUR, and current EBITDA margin is 16.17%. See more stats in HISAMITSU PHARMA. financial statements.
Like other stocks, HPX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HISAMITSU PHARMA. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HISAMITSU PHARMA. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HISAMITSU PHARMA. stock shows the sell signal. See more of HISAMITSU PHARMA. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.